Monogram Orthopaedics, Inc.
MGRM · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 50% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -660.5% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -998.7% | – |
| EPS Diluted | -0.16 | -0.096 | -0.13 | -0.16 |
| % Growth | -66.3% | 26% | 18.8% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |